Clinical Trials Study
Copyright ©The Author(s) 2018.
World J Cardiol. Nov 26, 2018; 10(11): 222-233
Published online Nov 26, 2018. doi: 10.4330/wjc.v10.i11.222
Table 1 Baseline characteristics of the optical coherence tomography study population
VariableOverall (n = 64)OCT-guided PCI (n = 38)OCT-guided OMT (n = 26)P-value
Age (yr)63.17 ± 9.6863.42 ± 9.8862.81 ± 9.560.806
Male (%)43 (67.2)25 (65.8)18 (69.2)0.773
Diabetes mellitus (%)10 (15.6)7 (18.4)3 (11.5)0.693
Hypertension (%)39 (60.9)22 (57.9)17 (65.4)0.546
Discharge treatment
Aspirin (%)64 (100)38 (100)26 (100)1
P2Y12 inhibitor (%)59 (92.2)38 (100)25 (96.1)0.406
Statin (%)64 (100)38 (100)26 (100)1
Beta-blocker (%)29 (45.3)19 (50)10 (38.5)0.362
ACE-I/ARB (%)33 (51.6)23 (60.5)10 (38.5)0.083
CCB (%)24 (37.5)13 (34.2)11 (42.3)0.511
Nitrates (%)36 (56.2)21 (55.3)15 (57.7)0.847
Admission diagnosis0.068
Stable angina (%)7 (10.9)4 (10.5)3 (11.5)
Unstable angina (%)53 (82.8)34 (89.5)19 (73.1)
NSTEMI (%)2 (3.1)0 (0)2 (7.7)
STEMI (%)2 (3.1)0 (0)2 (7.7)
ICL vessel0.671
LAD (%)37 (57.8)21 (55.3)16 (61.5)
LCX (%)12 (18.8)6 (15.8)6 (23.1)
RCA (%)15 (23.4)10 (26.3)5 (19.2)
Table 2 Two-dimensional quantitative coronary angiography findings pre-optical coherence tomography in the percutaneous coronary intervention and optimal medical therapy groups
VariableOCT-guided PCI (n = 38)OCT-guided OMT (n = 26)P-value
Reference area, mm27.91 (5.61-10.45)7.97 (6.01-11.16)0.538
Minimum luminal area, mm21.97 (1.37-2.80)2.40 (1.73-3.82)0.029
Area stenosis %74.02 ± 6.4367.77 ± 6.440.001
Table 3 Frequency-domain optical coherence tomography findings in the percutaneous coronary intervention and optimal medical therapy groups
VariableOCT-guided PCI (n = 38)OCT-guided OMT (n = 26)P-value
Reference area mm29.00 (7.56-11.21)9.32 (7.73-12.14)0.507
Minimum luminal area mm22.44 (1.93-3.15)3.43 (2.61-4.72)0.001
Area stenosis %72.22 ± 7.3961.87 ± 7.51< 0.001
Table 4 Two-dimensional quantitative coronary angiography vs frequency-domain optical coherence tomography findings
Group2D-QCAFD-OCTP-value
Reference area, mm2
OCT-guided PCI8.16 ± 3.249.39 ± 3.28< 0.001
OCT-guided OMT7.97 (6.01-11.16)9.32 (7.73-12.14)0.005
Minimum luminal area mm2
OCT-guided PCI2.14 ± 1.002.58 ± 1.04< 0.001
OCT-guided OMT2.40 (1.73-3.82)3.43 (2.61- 4.72)< 0.001
Area stenosis %
OCT-guided PCI74.02 ± 6.4472.22 ± 7.390.027
OCT-guided OMT67.77 ± 7.3161.87 ± 7.51< 0.001
Table 5 Clinical outcomes at 12 mo follow-up n (%)
VariableOCT-guided PCI (n = 38)OCT-guided OMT (n = 26)P-value, overall = 0.634
Myocardial infarction1 (2.6)01
Target lesion revascularisation1 (2.6)01
Re-angina13 (34.2)8 (30.8)0.603
Re-hospitalisation3 (7.9)2 (7.7)0.920
Minor bleeding events5 (13.2)1 (3.8)0.427